Sustained Release Excipients Market Size, Share and Growth Outlook 2026: By Product (Polymers, Gelatin, Minerals, Sugars, Alcohol, Chitosan), By Technology, By Route of Administration, By Application, Companies to 2034.
The global Sustained Release Excipients Market size is forecast to increase from $1.81 Billion in 2026 to $3.42 Billion in 2034 at a CAGR of 8.28% between 2026 and 2034.
The Sustained Release Excipients market report provides detailed analysis and outlook of Sustained Release Excipients segments including By Product (Polymers, Gelatin, Minerals, Sugars, Alcohol, Chitosan), By Technology (Targeted Delivery, Microencapsulation, Wurster Technique, Coacervation, Implants, Transdermal), By Route of Administration (Oral, Intravenous (IV), Transdermal, Intramuscular (IM), Vaginal, Ophthalmic), By Application (Pharmaceuticals, Nutraceuticals) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Sustained Release Excipients Industry Overview
Advanced excipient technologies are enabling the next generation of controlled drug delivery.
The global sustained release excipients industry is evolving as pharmaceutical manufacturers increasingly develop formulations that improve therapeutic efficacy, reduce dosing frequency, and enhance patient adherence. Growing demand for modified-release oral medicines, long-acting injectable therapies, implantable drug delivery systems, and targeted gastrointestinal formulations is driving innovation in functional polymers, coating materials, and bioresorbable matrices. Excipient manufacturers are investing in advanced material science, continuous manufacturing technologies, and formulation support services to help drug developers optimize release kinetics while meeting stringent regulatory and quality requirements. These developments are strengthening the strategic role of sustained release excipients throughout modern pharmaceutical development and commercial manufacturing.
Functional polymers and targeted delivery systems are expanding formulation capabilities.
Manufacturers are introducing highly engineered excipients that improve drug release control while increasing formulation flexibility across diverse dosage forms. Ashland showcased its Klucel™ XTEND Hydroxypropylcellulose polymer, demonstrating sustained-release performance comparable to conventional hypromellose formulations at significantly lower polymer concentrations, enabling reduced tablet size or higher active pharmaceutical ingredient loading. The company also highlighted Viatel™ Ultrapure Bioresorbable Polymers manufactured under GMP conditions for long-acting depot injections and implantable drug delivery systems designed to minimize undesirable initial burst release. Evonik further strengthened its leadership in functional excipients through industry recognition for EUDRAGIT® sustained and delayed-release coating polymers and EUDRACAP® functional capsules developed for targeted ileo-colonic drug delivery and protection of sensitive biological ingredients.
Continuous manufacturing is accelerating development of sustained-release formulations.
The industry is increasingly adopting flexible manufacturing technologies that enable faster formulation optimization while reducing development timelines. DFE Pharma expanded technical support capabilities through the launch of its Continuous Manufacturing platform at the Closer to the Formulator Center of Excellence in Hyderabad, developed in collaboration with Gericke. The modular system enables pharmaceutical developers to conduct rapid feasibility studies and optimize powder feeding and blending conditions for modified and sustained-release oral solid dosage formulations without interrupting commercial GMP production. Across the sustained release excipients industry, manufacturers continue investing in advanced formulation technologies, process innovation, and technical development infrastructure to support increasingly sophisticated drug delivery systems across global pharmaceutical markets.
Sustained Release Excipients Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Sustained Release Excipients market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- BASF SE, Ashland Global Holdings Inc., Evonik Industries AG, Colorcon Inc., Croda International Plc, Merck KGaA, Roquette Fr?res, The Lubrizol Corporation, Shin-Etsu Chemical Co., Ltd., JRS Pharma GmbH & Co. KG. The Sustained Release Excipients market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Sustained Release Excipients industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Sustained Release Excipients industry include- BASF SE, Ashland Global Holdings Inc., Evonik Industries AG, Colorcon Inc., Croda International Plc, Merck KGaA, Roquette Fr?res, The Lubrizol Corporation, Shin-Etsu Chemical Co., Ltd., JRS Pharma GmbH & Co. KG. The Sustained Release Excipients market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Sustained Release Excipients Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Sustained Release Excipients market remains one of the strongest-performing segments in the country.
The US Sustained Release Excipients Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Sustained Release Excipients market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Sustained Release Excipients industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Sustained Release Excipients markets
Canada's strong Sustained Release Excipients sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Sustained Release Excipients market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Sustained Release Excipients Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Sustained Release Excipients market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Sustained Release Excipients population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Sustained Release Excipients industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Sustained Release Excipients market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Sustained Release Excipients sales through 2034
France Sustained Release Excipients companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Sustained Release Excipients Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Sustained Release Excipients distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Sustained Release Excipients Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Sustained Release Excipients market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Sustained Release Excipients industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Sustained Release Excipients industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Sustained Release Excipients Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Sustained Release Excipients market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Sustained Release Excipients market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Sustained Release Excipients Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Sustained Release Excipients Market Segmentation
By Product
Polymers
Gelatin
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Microencapsulation
Wurster Technique
Coacervation
Implants
Transdermal
By Route of Administration
Oral
Intravenous (IV)
Transdermal
Intramuscular (IM)
Vaginal
Ophthalmic
By Application
Pharmaceuticals
Nutraceuticals
Leading Companies in Sustained Release Excipients Industry (2026)
BASF SE
Ashland Global Holdings Inc.
Evonik Industries AG
Colorcon Inc.
Croda International Plc
Merck KGaA
Roquette Fr?res
The Lubrizol Corporation
Shin-Etsu Chemical Co., Ltd.
JRS Pharma GmbH & Co. KG
Countries Included
The Sustained Release Excipients market report provides detailed analysis and outlook of Sustained Release Excipients segments including By Product (Polymers, Gelatin, Minerals, Sugars, Alcohol, Chitosan), By Technology (Targeted Delivery, Microencapsulation, Wurster Technique, Coacervation, Implants, Transdermal), By Route of Administration (Oral, Intravenous (IV), Transdermal, Intramuscular (IM), Vaginal, Ophthalmic), By Application (Pharmaceuticals, Nutraceuticals) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Sustained Release Excipients Industry Overview
Advanced excipient technologies are enabling the next generation of controlled drug delivery.
The global sustained release excipients industry is evolving as pharmaceutical manufacturers increasingly develop formulations that improve therapeutic efficacy, reduce dosing frequency, and enhance patient adherence. Growing demand for modified-release oral medicines, long-acting injectable therapies, implantable drug delivery systems, and targeted gastrointestinal formulations is driving innovation in functional polymers, coating materials, and bioresorbable matrices. Excipient manufacturers are investing in advanced material science, continuous manufacturing technologies, and formulation support services to help drug developers optimize release kinetics while meeting stringent regulatory and quality requirements. These developments are strengthening the strategic role of sustained release excipients throughout modern pharmaceutical development and commercial manufacturing.
Functional polymers and targeted delivery systems are expanding formulation capabilities.
Manufacturers are introducing highly engineered excipients that improve drug release control while increasing formulation flexibility across diverse dosage forms. Ashland showcased its Klucel™ XTEND Hydroxypropylcellulose polymer, demonstrating sustained-release performance comparable to conventional hypromellose formulations at significantly lower polymer concentrations, enabling reduced tablet size or higher active pharmaceutical ingredient loading. The company also highlighted Viatel™ Ultrapure Bioresorbable Polymers manufactured under GMP conditions for long-acting depot injections and implantable drug delivery systems designed to minimize undesirable initial burst release. Evonik further strengthened its leadership in functional excipients through industry recognition for EUDRAGIT® sustained and delayed-release coating polymers and EUDRACAP® functional capsules developed for targeted ileo-colonic drug delivery and protection of sensitive biological ingredients.
Continuous manufacturing is accelerating development of sustained-release formulations.
The industry is increasingly adopting flexible manufacturing technologies that enable faster formulation optimization while reducing development timelines. DFE Pharma expanded technical support capabilities through the launch of its Continuous Manufacturing platform at the Closer to the Formulator Center of Excellence in Hyderabad, developed in collaboration with Gericke. The modular system enables pharmaceutical developers to conduct rapid feasibility studies and optimize powder feeding and blending conditions for modified and sustained-release oral solid dosage formulations without interrupting commercial GMP production. Across the sustained release excipients industry, manufacturers continue investing in advanced formulation technologies, process innovation, and technical development infrastructure to support increasingly sophisticated drug delivery systems across global pharmaceutical markets.
Sustained Release Excipients Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Sustained Release Excipients market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- BASF SE, Ashland Global Holdings Inc., Evonik Industries AG, Colorcon Inc., Croda International Plc, Merck KGaA, Roquette Fr?res, The Lubrizol Corporation, Shin-Etsu Chemical Co., Ltd., JRS Pharma GmbH & Co. KG. The Sustained Release Excipients market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Sustained Release Excipients industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Sustained Release Excipients Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Sustained Release Excipients companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Sustained Release Excipients markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Sustained Release Excipients industry include- BASF SE, Ashland Global Holdings Inc., Evonik Industries AG, Colorcon Inc., Croda International Plc, Merck KGaA, Roquette Fr?res, The Lubrizol Corporation, Shin-Etsu Chemical Co., Ltd., JRS Pharma GmbH & Co. KG. The Sustained Release Excipients market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Sustained Release Excipients Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Sustained Release Excipients market remains one of the strongest-performing segments in the country.
The US Sustained Release Excipients Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Sustained Release Excipients market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Sustained Release Excipients industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Sustained Release Excipients markets
Canada's strong Sustained Release Excipients sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Sustained Release Excipients market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Sustained Release Excipients Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Sustained Release Excipients market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Sustained Release Excipients population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Sustained Release Excipients industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Sustained Release Excipients market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Sustained Release Excipients sales through 2034
France Sustained Release Excipients companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Sustained Release Excipients Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Sustained Release Excipients distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Sustained Release Excipients Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Sustained Release Excipients market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Sustained Release Excipients industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Sustained Release Excipients industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Sustained Release Excipients Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Sustained Release Excipients market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Sustained Release Excipients market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Sustained Release Excipients Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Sustained Release Excipients Market Segmentation
By Product
Polymers
Gelatin
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Microencapsulation
Wurster Technique
Coacervation
Implants
Transdermal
By Route of Administration
Oral
Intravenous (IV)
Transdermal
Intramuscular (IM)
Vaginal
Ophthalmic
By Application
Pharmaceuticals
Nutraceuticals
Leading Companies in Sustained Release Excipients Industry (2026)
BASF SE
Ashland Global Holdings Inc.
Evonik Industries AG
Colorcon Inc.
Croda International Plc
Merck KGaA
Roquette Fr?res
The Lubrizol Corporation
Shin-Etsu Chemical Co., Ltd.
JRS Pharma GmbH & Co. KG
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Sustained Release Excipients Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Sustained Release Excipients Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Sustained Release Excipients Markets in 2026
3.2. Global Historic and Forecast Sustained Release Excipients Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Sustained Release Excipients Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Sustained Release Excipients Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Sustained Release Excipients Value Chain
CHAPTER 4- SUSTAINED RELEASE EXCIPIENTS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Sustained Release Excipients Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SUSTAINED RELEASE EXCIPIENTS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product
Polymers
Gelatin
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Microencapsulation
Wurster Technique
Coacervation
Implants
Transdermal
By Route of Administration
Oral
Intravenous (IV)
Transdermal
Intramuscular (IM)
Vaginal
Ophthalmic
By Application
Pharmaceuticals
Nutraceuticals
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Sustained Release Excipients Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Sustained Release Excipients Market Trends and Growth Opportunities to 2034
7.5. North America Sustained Release Excipients Market Size Outlook by Type
7.6. North America Sustained Release Excipients Market Size Outlook by Application
7.7. North America Sustained Release Excipients Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Sustained Release Excipients Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Sustained Release Excipients Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Sustained Release Excipients Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Sustained Release Excipients Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Sustained Release Excipients Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Sustained Release Excipients Companies
CHAPTER 8- EUROPE SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Sustained Release Excipients Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Sustained Release Excipients Market Trends and Growth Opportunities to 2034
8.5. Europe Sustained Release Excipients Market Size Outlook by Type
8.6. Europe Sustained Release Excipients Market Size Outlook by Application
8.7. Europe Sustained Release Excipients Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Sustained Release Excipients Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Sustained Release Excipients Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Sustained Release Excipients Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Sustained Release Excipients Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Sustained Release Excipients Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Sustained Release Excipients Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Sustained Release Excipients Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Sustained Release Excipients Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Sustained Release Excipients Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Sustained Release Excipients Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Sustained Release Excipients Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Sustained Release Excipients Companies
CHAPTER 9- ASIA PACIFIC SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Sustained Release Excipients Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Sustained Release Excipients Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Sustained Release Excipients Market Size Outlook by Type
9.6. Asia Pacific Sustained Release Excipients Market Size Outlook by Application
9.7. Asia Pacific Sustained Release Excipients Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Sustained Release Excipients Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Sustained Release Excipients Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Sustained Release Excipients Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Sustained Release Excipients Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Sustained Release Excipients Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Sustained Release Excipients Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Sustained Release Excipients Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Sustained Release Excipients Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Sustained Release Excipients Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Sustained Release Excipients Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Sustained Release Excipients Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Sustained Release Excipients Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Sustained Release Excipients Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Sustained Release Excipients Market Trends and Growth Opportunities to 2034
10.5. South and Central America Sustained Release Excipients Market Size Outlook by Type
10.6. South and Central America Sustained Release Excipients Market Size Outlook by Application
10.7. South and Central America Sustained Release Excipients Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Sustained Release Excipients Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Sustained Release Excipients Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Sustained Release Excipients Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Sustained Release Excipients Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Sustained Release Excipients Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Sustained Release Excipients Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Sustained Release Excipients Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Sustained Release Excipients Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Sustained Release Excipients Market Size Outlook by Type
11.6. Middle East and Africa Sustained Release Excipients Market Size Outlook by Application
11.7. Middle East and Africa Sustained Release Excipients Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Sustained Release Excipients Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Sustained Release Excipients Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Sustained Release Excipients Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Sustained Release Excipients Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Sustained Release Excipients Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Sustained Release Excipients Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Sustained Release Excipients Industry
BASF SE
Ashland Global Holdings Inc.
Evonik Industries AG
Colorcon Inc.
Croda International Plc
Merck KGaA
Roquette Fr?res
The Lubrizol Corporation
Shin-Etsu Chemical Co., Ltd.
JRS Pharma GmbH & Co. KG
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Sustained Release Excipients Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Sustained Release Excipients Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Sustained Release Excipients Markets in 2026
3.2. Global Historic and Forecast Sustained Release Excipients Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Sustained Release Excipients Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Sustained Release Excipients Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Sustained Release Excipients Value Chain
CHAPTER 4- SUSTAINED RELEASE EXCIPIENTS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Sustained Release Excipients Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SUSTAINED RELEASE EXCIPIENTS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product
Polymers
Gelatin
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Microencapsulation
Wurster Technique
Coacervation
Implants
Transdermal
By Route of Administration
Oral
Intravenous (IV)
Transdermal
Intramuscular (IM)
Vaginal
Ophthalmic
By Application
Pharmaceuticals
Nutraceuticals
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Sustained Release Excipients Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Sustained Release Excipients Market Trends and Growth Opportunities to 2034
7.5. North America Sustained Release Excipients Market Size Outlook by Type
7.6. North America Sustained Release Excipients Market Size Outlook by Application
7.7. North America Sustained Release Excipients Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Sustained Release Excipients Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Sustained Release Excipients Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Sustained Release Excipients Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Sustained Release Excipients Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Sustained Release Excipients Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Sustained Release Excipients Companies
CHAPTER 8- EUROPE SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Sustained Release Excipients Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Sustained Release Excipients Market Trends and Growth Opportunities to 2034
8.5. Europe Sustained Release Excipients Market Size Outlook by Type
8.6. Europe Sustained Release Excipients Market Size Outlook by Application
8.7. Europe Sustained Release Excipients Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Sustained Release Excipients Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Sustained Release Excipients Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Sustained Release Excipients Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Sustained Release Excipients Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Sustained Release Excipients Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Sustained Release Excipients Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Sustained Release Excipients Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Sustained Release Excipients Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Sustained Release Excipients Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Sustained Release Excipients Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Sustained Release Excipients Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Sustained Release Excipients Companies
CHAPTER 9- ASIA PACIFIC SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Sustained Release Excipients Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Sustained Release Excipients Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Sustained Release Excipients Market Size Outlook by Type
9.6. Asia Pacific Sustained Release Excipients Market Size Outlook by Application
9.7. Asia Pacific Sustained Release Excipients Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Sustained Release Excipients Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Sustained Release Excipients Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Sustained Release Excipients Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Sustained Release Excipients Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Sustained Release Excipients Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Sustained Release Excipients Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Sustained Release Excipients Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Sustained Release Excipients Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Sustained Release Excipients Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Sustained Release Excipients Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Sustained Release Excipients Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Sustained Release Excipients Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Sustained Release Excipients Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Sustained Release Excipients Market Trends and Growth Opportunities to 2034
10.5. South and Central America Sustained Release Excipients Market Size Outlook by Type
10.6. South and Central America Sustained Release Excipients Market Size Outlook by Application
10.7. South and Central America Sustained Release Excipients Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Sustained Release Excipients Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Sustained Release Excipients Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Sustained Release Excipients Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Sustained Release Excipients Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Sustained Release Excipients Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Sustained Release Excipients Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SUSTAINED RELEASE EXCIPIENTS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Sustained Release Excipients Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Sustained Release Excipients Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Sustained Release Excipients Market Size Outlook by Type
11.6. Middle East and Africa Sustained Release Excipients Market Size Outlook by Application
11.7. Middle East and Africa Sustained Release Excipients Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Sustained Release Excipients Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Sustained Release Excipients Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Sustained Release Excipients Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Sustained Release Excipients Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Sustained Release Excipients Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Sustained Release Excipients Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Sustained Release Excipients Industry
BASF SE
Ashland Global Holdings Inc.
Evonik Industries AG
Colorcon Inc.
Croda International Plc
Merck KGaA
Roquette Fr?res
The Lubrizol Corporation
Shin-Etsu Chemical Co., Ltd.
JRS Pharma GmbH & Co. KG
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
